Genetic variants and differential expression of the ACTN1 have been reported in various diseases, including congenital macrothrombocytopenia, Angelman syndrome, Bowen disease, postmenopausal osteoporosis, lupus erythematosus, and COVID-19 [54–57, 69, 70]. This evidence concerns the gene ACTN1 and Angelman syndrome.